Dilek Arikan

Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis

Gerd R Burmester, Kenneth B. Gordon, James T. Rosenbaum et al. · Advances in Therapy · 2019 · 90 citations · Full text

A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results

Michael J. Kozal, Sergio Lupo, Edwin DeJesus et al. · HIV Clinical Trials · 2012 · 85 citations

Open : Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-up in the PYRAMID Registry

Geert D’Haens, Walter Reinisch, Remo Panaccione et al. · The American Journal of Gastroenterology · 2018 · 72 citations · Full text

Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease

Gerd Horneff, Marieke M.B. Seyger, Dilek Arikan et al. · The Journal of Pediatrics · 2018 · 51 citations · Full text

Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry

Alan Menter, Diamant Thaçi, Jashin J. Wu et al. · Dermatology and Therapy · 2017 · 46 citations · Full text